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Astigmatism is a commonly occurring refractive error 
that leads to impaired visual acuity if uncorrected and is 
a risk factor for amblyopia [1-4]. The two major sources 
of refractive astigmatism in the human eye are the cornea 
and the crystalline lens. In emmetropic eyes, a low degree 
of with-the-rule (WTR) corneal astigmatism is typically 
compensated by a low degree of against-the-rule (ATR) 
lenticular astigmatism [5]. For individuals with higher levels 
of refractive astigmatism, corneal astigmatism is usually the 
major contributor, while lenticular astigmatism is within the 
normal range [6].
Studies in chicks have recently shown that the eye can 
compensate for experimentally induced astigmatism through 
the alteration of corneal curvature [7]. This suggests that 
the reduction in innate astigmatism seen during infancy in 
children occurs via active emmetropization [8]. Potential 
reasons why astigmatism still arises despite the presence 
of an emmetropization system include (a) astigmatism of 
too high a degree to be compensated within the juvenile 
period, (b) astigmatism outside the “operating range” of the 
emmetropization system, for example, producing a retinal 
image that is not detected as being caused by astigmatism 
or that arises at an age beyond that at which emmetropiza-
tion normally acts, and (c) a failure of the emmetropization 
response [2].
Several lines of evidence support the role of genetics in 
the etiology of astigmatism. First, epidemiology studies have 
shown marked differences in the prevalence of astigmatism 
across ethnic groups, even after accounting for differences 
in spherical refractive error. For instance, 78% of native 
American Tohono O’odham children aged 0–8 have at least 1 
diopter (D) of corneal astigmatism, and in Australian children 
aged 12, at least 1 D of corneal astigmatism was found in 19% 
of European individuals versus 50% of East Asian individuals 
[9,10]. Second, corneal and refractive astigmatism have been 
reported as being moderately/highly heritable (heritability 
of 0.3–0.6) in twin studies [11,12]. Third, a genetic segrega-
tion study in families with high-degree astigmatism found 
evidence of Mendelian inheritance [13]. Finally, genetic 
association studies have identified specific genetic variants 
associated with susceptibility to either refractive and/or 
corneal astigmatism [14-17]. Despite these latter studies, our 
understanding of the genetic contribution to astigmatism has 
lagged behind that of spherical refractive errors, for which 
dozens of genetic variants have been discovered [18-21].
Previously, the Consortium for Refractive Error and 
Myopia (CREAM) reported a genome-wide association 
study (GWAS) of refractive astigmatism that examined 
approximately two million genetic markers in 45,931 indi-
viduals [17]. Only a single marker reached genome-wide 
significance (rs1401327 in the NRXN1 gene, p=3.92E−8). 
Reasoning that the paucity of genome-wide significant hits 
in the previous CREAM study may have been due to pheno-
typic uncertainty when studying refractive astigmatism that 
arose from the combination of both corneal and lenticular 
influence, CREAM has now undertaken a GWAS of corneal 
astigmatism. Fan et al. [16] performed a GWAS of corneal 
astigmatism using a discovery sample of 4,254 East Asian 
individuals and identified a genome-wide significant locus 
near the PDGFRA gene. In view of the success of the Fan 
et al. [16] study, the current analysis has adopted the same 
phenotype definition.
Purpose: To identify genes and genetic markers associated with corneal astigmatism.
Methods: A meta-analysis of genome-wide association studies (GWASs) of corneal astigmatism undertaken for 14 
European ancestry (n=22,250) and 8 Asian ancestry (n=9,120) cohorts was performed by the Consortium for Refractive 
Error and Myopia. Cases were defined as having >0.75 diopters of corneal astigmatism. Subsequent gene-based and gene-
set analyses of the meta-analyzed results of European ancestry cohorts were performed using VEGAS2 and MAGMA 
software. Additionally, estimates of single nucleotide polymorphism (SNP)-based heritability for corneal and refractive 
astigmatism and the spherical equivalent were calculated for Europeans using LD score regression.
Results: The meta-analysis of all cohorts identified a genome-wide significant locus near the platelet-derived growth 
factor receptor alpha (PDGFRA) gene: top SNP: rs7673984, odds ratio=1.12 (95% CI:1.08–1.16), p=5.55×10−9. No other 
genome-wide significant loci were identified in the combined analysis or European/Asian ancestry-specific analyses. 
Gene-based analysis identified three novel candidate genes for corneal astigmatism in Europeans—claudin-7 (CLDN7), 
acid phosphatase 2, lysosomal (ACP2), and TNF alpha-induced protein 8 like 3 (TNFAIP8L3).
Conclusions: In addition to replicating a previously identified genome-wide significant locus for corneal astigmatism 
near the PDGFRA gene, gene-based analysis identified three novel candidate genes, CLDN7, ACP2, and TNFAIP8L3, 
that warrant further investigation to understand their role in the pathogenesis of corneal astigmatism. The much lower 
number of genetic variants and genes demonstrating an association with corneal astigmatism compared to published 
spherical equivalent GWAS analyses suggest a greater influence of rare genetic variants, non-additive genetic effects, 
or environmental factors in the development of astigmatism.
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METHODS
The research study followed an analysis plan that was agreed 
upon by members of CREAM before starting work. This plan 
was designed to standardize methods across participating 
CREAM groups and to set timelines for the completion 
of specific tasks. All research groups known to CREAM 
with relevant genotype and phenotype data were invited to 
contribute to the study. Ethical approval for the study was 
obtained locally for each CREAM study group, and partici-
pants gave informed consent. The research was carried out 
in accordance with the tenets of the Declaration of Helsinki.
Study sample: The demographics of the participating study 
groups are shown in Table 1. The participants comprised 
22,250 European individuals from 14 studies and 9,120 
Asian individuals from 8 studies. There were 5,470 European 
participants and 947 Asian participants aged <25 years.
Phenotype definition: Following Fan et al. [16], cases were 
defined as participants with corneal astigmatism >0.75 D, 
and controls were defined as those with corneal astigmatism 
≤0.75 D. Corneal astigmatism was averaged between the two 
eyes, except for participants with data available for only one 
eye. For the conversion of keratometry readings in millime-
ters to diopters, we used a conversion factor of 332 divided 
by the K-reading in mm [22].
Phenotyping, genotyping, and genetic imputation: Anterior 
corneal curvature was measured using keratometry (the 
keratometer used by each CREAM study group is listed in 
Appendix 1), and corneal astigmatism was calculated as the 
difference in curvature between the steepest and flattest 
meridians. Participants known to have keratoconus, corneal 
scarring, ocular surgery, or any corneal/ocular condition 
that would impair keratometry were excluded from the 
analysis. DNA samples were extracted from blood or saliva 
and genotyped on a high-density single nucleotide polymor-
phism (SNP) platform, as previously described [17]. Each 
CREAM study group imputed non-genotyped markers from 
an ancestry-matched reference panel from the 1000 Genomes 
Project [17] using IMPUTE2 [23] or Minimac [24]. Quality-
control filtering was performed in accordance with standard 
GWAS practices [25]. In general, markers with per-study 
missingness <0.95, minor allele frequency (MAF) <0.05, 
or a Hardy–Weinberg disequilibrium p value <1×10−6 were 
excluded, along with samples with per-study missingness 
<0.95, extreme heterozygosity, sex mismatch, unaccounted 
for relatedness, or outlying ancestry [25]. Poorly imputed 
markers (IMPUTE2 info ≤0.5 or Minimac Rsq ≤0.5) were 
also excluded.
Genome-wide association studies and meta-analyses: Tests 
of association between corneal astigmatism case/control 
status and SNP genotype were performed genome-wide by 
each participating CREAM study group. The analysis was 
performed using PLINK [26] for marker genotypes coded 0, 
1, or 2 or using mach2dat [24] or ProbABEL [27] for marker 
genotypes coded as imputed dosage on the scale 0–2. Age 
and sex were included as a continuous and a binary covariate, 
respectively. The first five major principal components were 
also included as continuous covariates if there was evidence 
of population stratification from Q-Q plots or the genomic 
control inflation factor (λGC). For samples of related individ-
uals, the analysis method took account of genetic background 
by treating this as a random effect in the analysis model. Tests 
of association were conducted separately for participants of 
European ancestry and participants of Asian ancestry and for 
younger (age >3 and <25) and older (age ≥25) participants.
Summary statistics from the participating CREAM 
study groups were submitted to a central site for meta-
analysis. Using the approach implemented in easyQC [28], 
the summary statistics were evaluated by examining quality 
control plots and metrics, including effect allele frequency 
(EAF) plots, p value versus z-score (P-Z) plots, standard error 
versus sample size (SE-N) plots, effect size (odds ratio) distri-
butions, and genomic control inflation factors. Queries were 
resolved by discussion with study groups analysts, and, where 
indicated, imputation or association testing was repeated.
Meta-analyses were performed separately for the 
four demographic strata—younger/older, European/Asian 
ancestry individuals. Fixed effects, standard error-weighted 
meta-analysis [29] was performed initially, followed by a 
random effects meta-analysis [30] for highly associated 
markers showing excessive between-study heterogeneity of 
I2>0.5, where I2 is a measure of heterogeneity derived from 
Cochran’s Q statistic [31]. A p value of 5×10−8 was adopted for 
declaring genome-wide significant association in the GWAS 
meta-analyses [32]. Regional association plots were created 
using LocusZoom [33]. Conditional analysis was performed 
on GWAS meta-analysis summary statistics using GCTA-
COJO [34].
Gene-based tests and pathway analysis: Two gene-based 
tests, VEGAS2 [35] and MAGMA [36], were used to explore 
whether specific genes were enriched with strongly associ-
ated variants in the GWAS meta-analysis of older European 
individuals. Attention was restricted to the older European 
samples because gene-based testing relies on consistent 
patterns of linkage disequilibrium (LD) across genes, and 
the sample size was larger for the European meta-analysis 
compared to that for the Asian cohorts. Markers within 50 
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kb upstream and downstream of a gene were included in 
the gene-based tests, with the aim of detecting variants that 
altered the expression level of genes. The gene-based testing 
using MAGMA was repeated using an extended flanking 
region of 200 kb upstream and downstream of genes.
VEGAS2 [35] uses a fast approximation of a permuta-
tion-based test to determine whether genes are enriched for 
highly associated markers and makes use of LD information 
from an ancestry-matched reference panel to account for 
association signals shared by markers in LD. The test was 
implemented to analyze all markers in each gene. MAGMA 
[36] overcomes the low statistical power inherent when a gene 
contains many markers, some of which may be in strong LD, 
by first carrying out a principal components analysis (PCA) 
for the markers in each gene and then carrying out a per-
gene linear regression analysis using the PCA eigenvectors 
as predictor variables. High statistical power is attained by 
limiting the regression to the major eigenvalues. Permutation-
based p values are calculated to account for the use of a binary 
outcome as the dependent variable in the linear regression 
analysis [36].
Gene-set “pathway analysis” was also performed using 
MAGMA [36]. This was performed using a competitive 
approach whereby the test statistics for all genes within a 
gene set were combined to form a joint association statistic. 
This statistic was compared against that for all other genes not 
in that set while accounting for the number of SNPs within 
each gene, gene density, and differential sample size (unequal 
sample size contributing to each gene) [36]. Gene sets were 
defined using the Molecular Signatures Database (MSigDB) 
[37]. Gene definitions and their respective association signals 
for genes contributing to gene sets were taken from the 
MAGMA gene-based analyses with the aim of identifying 
potential biologic processes that may be influenced by these 
variants.
Shared genetic contribution to traits: LD score regression 
[38,39] was used to quantify the degree of shared genetic 
contribution between corneal astigmatism and two related 
traits, refractive astigmatism and mean spherical equivalent 
refractive error. GWAS summary statistics for refractive 
astigmatism and for spherical equivalent refractive error were 
obtained from previous CREAM studies [17,18]. LD score 
regression utilizes LD information from an ancestry-matched 
reference panel and requires large sample sizes; therefore, 
analyses were limited to European GWAS samples. Specifi-
cally, LD score regression was performed using the LDSC 
program [38,39] for variants present in the HapMap3 CEU 
reference panel with MAF ≥0.05. The prevalence of corneal 
astigmatism (defined as an amount >0.75 D) in the general 
population was taken as 42%, which was calculated as the 
average for the European ancestry population-based studies 
contributing to this meta-analysis. LD score regression 
remains valid when two traits are measured in overlapping 
samples [39], which was the case for these CREAM GWAS 
samples.
RESULTS
Meta-analysis of genome-wide association studies: Meta-
analyses were performed using a fixed effects model for 
approximately six million genetic variants (approximately 
5,500,000 SNPs and 380,000 indels) in each of the four 
ancestry/age strata (younger European, older European, 
Figure 1. Manhattan plot showing 
most strongly associated markers 
in the GWAS fixed-effects meta-
analysis for European and Asian 
participants of all ages combined 
(n=31,375). Red line: p=5×10−8, blue 
line: p=1×10−5.
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Figure 2. Q-Q plot for the GWAS 
fixed-effects meta-analysis for 
European and Asian participants of 
all ages combined (n=31,375).
Figure 3. Region plot for the most 
strongly associated region in the 
GWAS fixed-effects meta-analysis 
for European and Asian participants 
of all ages combined (n=31,375).
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Table 2. moST STrongly aSSociaTed marker in each region in The gWaS meTa-anal-
ySiS of all SampleS (europeanS and aSianS of all ageS combined). 
SNP Chr Pos Effect allele Other allele EAF OR (95%CI) P value Nearest gene
rs7673984 4 55,088,761 T C 0.22 1.12 (1.08–1.16) 5.55×10−9 PDGFRA
rs34751092 4 24,129,037 A G 0.28 1.09 (1.05–1.13) 6.07×10−7 PPARGC1A
rs630203 5 141,444,269 T G 0.74 0.92 (0.88–0.95) 8.83×10−7 MRPL11P2
rs75607298 8 128,611,496 A G 0.72 1.14 (1.08–1.21) 2.28×10−6 CASC11
rs62401199 6 43,813,341 T C 0.14 1.15 (1.09–1.22) 3.29×10−6 LINC01512
rs753992 11 47,349,846 A G 0.29 0.91 (0.87–0.95) 3.48×10−6 MADD
rs3214101 11 114,009,408 A T 0.68 1.08 (1.05–1.12) 3.75×10−6 ZBTB16
rs10985068 9 123,629,724 C G 0.12 1.13 (1.07–1.19) 5.87×10−6 PHF19
rs62128379 2 26,960,055 T C 0.85 1.13 (1.07–1.19) 6.00×10−6 KCNK3
rs9939114 16 84,023,972 A G 0.05 0.54 (0.41–0.70) 6.01×10−6 NECAB2
rs60083876 7 34,228,819 A T 0.95 1.31 (1.17–1.48) 6.53×10−6 BMPER
rs859362 1 175,495,090 T C 0.19 1.10 (1.05–1.15) 7.14×10−6 TNR
rs11775037 8 108,317,615 A G 0.20 1.10 (1.05–1.14) 7.31×10−6 ANGPT1
rs7036824 9 96,149,894 T C 0.94 0.83 (0.77–0.90) 8.78×10−6 C9orf129
rs142168171 7 71,253,651 I R 0.09 1.37 (1.19–1.57) 9.14×10−6 CALN1
rs7278671 21 41,047,876 A G 0.51 0.93 (0.90–0.96) 9.31×10−6 B3GALT5
rs191640722 1 119,264,997 C G 0.09 0.87 (0.82–0.93) 9.53×10−6 LOC100421281
rs36107906 2 44,162,800 D R 0.29 1.09 (1.05–1.13) 9.61×10−6 LRPPRC
rs4896367 6 138,807,281 T C 0.72 1.09 (1.05–1.14) 9.75×10−6 NHSL1
rs35587414 1 153,174,958 T C 0.15 1.13 (1.07–1.20) 9.79×10−6 LELP1
EAF=effect allele frequency, OR=odds ratio.
Figure 4. Forest plot and summary 
table for lead variant rs7673984 
across all cohorts. Studies listed 
above the dotted line are new 
cohorts not included in the only 
prior GWAS for corneal astig-
matism [16]. EAF=effect allele 
frequency. (Note that rs7673984 
was excluded from the Rotterdam-
I cohort analysis during quality 
control filtering).
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younger Asian, and older Asian). However, none of the 
markers had a p value below the pre-determined threshold of 
5×10−8 used to declare genome-wide significance (Appendix 
2, Appendix 3, Appendix 4, Appendix 5, Appendix 6, and 
Appendix 7). Therefore, to increase power, a meta-analysis 
was performed using data for all four ancestry/age strata, 
under the assumption that the genetic determinants of 
corneal astigmatism are consistent across ancestry groups 
and lifespan. This yielded 49 markers with p values <5×10−8, 
all of which were located in a narrow interval on chromo-
some 4 close to the PDGFRA gene (Figure 1, Figure 2, and 
Figure 3). This locus has previously been identified in GWAS 
analyses for corneal astigmatism [16], refractive astigmatism 
[17], and corneal curvature [15,40,41]. Table 2 lists the most 
strongly associated marker in each region showing sugges-
tive association, defined as a region with at least one marker 
with p<1×10−5. Both the European and Asian meta-analyses 
contributed to the association signal at the PDGFRA locus; 
the most strongly associated marker, rs7673984, had an effect 
size (odds ratio) of OR=1.15 (95% CI:1.07–1.24; p=1.76×10−4) 
in Asians, OR=1.11 (95% CI:1.06–1.16; p=5.64×10−6) in Euro-
peans, and OR=1.12 (95% CI:1.08–1.16; p=5.55×10−9) in the 
meta-analysis of Asians and Europeans. The association of 
rs7673984 in the individual cohorts examined is summarized 
in Figure 4. Conditional analysis using GCTA-COJO yielded 
no additional association signals at the PDGRFA locus inde-
pendent of rs7673984.
Gene-based analyses: To explore whether specific genes were 
enriched for markers with low p values in the GWAS meta-
analysis, we performed gene-based tests using VEGAS2 [35] 
and MAGMA [36]. These programs use different approaches 
to test for such enrichment (see Methods). Due to the require-
ment for an ancestry-matched reference panel, analyses were 
conducted using the results of a GWAS meta-analysis of 
European samples of all ages (however, similar results were 
obtained when attention was restricted to the meta-analysis of 
older Europeans). The 10 most strongly associated genes from 
the VEGAS2 and MAGMA analyses are shown in Appendix 
8 and Appendix 9. There was a high degree of overlap 
between the results of the two programs, with the genes ACP2, 
CLDN7, ELP5, and CTDNEP1 showing the strongest associa-
tion in both analyses (Appendix 8 and Appendix 9). In the 
MAGMA gene-based test, these four genes and TNFAIP8L3 
achieved p<0.05 after stringent Bonferroni correction, 
whereas this was not the case for VEGAS (Appendix 8 and 
Appendix 9). A further exploratory gene-based analysis that 
included markers up to 200 kb upstream or downstream of 
each gene—an approach that has been successful for certain 
traits [42]—failed to identify any additional genes associated 
with corneal astigmatism.
Pathway analysis: As biologic processes tend to involve 
multiple genes, a gene-set analysis was performed with 
MAGMA [36] using the gene-based analysis results for the 
European samples. Gene-set analyses seek to identify poten-
tial biologic mechanisms enriched for genes with markers 
attaining low p values in the GWAS meta-analysis. However, 
no gene sets were identified as demonstrating a greater level 
of association with corneal astigmatism than would be 
expected by chance (when flanking regions of either ±50 kb 
or ±200 kb upstream or downstream of genes were tested).
SNP heritability and genetic correlation between traits: 
LD score regression was used to quantify the heritability 
explained by commonly occurring genetic variants (“SNP 
heritability”) and the degree of genetic sharing between 
corneal astigmatism and two related traits, refractive 
Table 3. Snp-heriTabiliTy eSTimaTed uSing ld Score regreSSion (europeanS only).
Trait No. of Markers SNP-heritability (SE) P value
Corneal Astigmatism 1,024,525 0.0555 (0.0381) 0.15
Refractive Astigmatism 1,056,658 0.0136 (0.0218) 0.53
Mean Spherical Equivalent 1,056,658 0.2326 (0.0175) 2.60×10−40
Table 4. geneTic correlaTionS beTWeen pairS of refracTive error TraiTS in SampleS of euro-
pean anceSTry from The cream conSorTium (uSing ld Score regreSSion).
Trait Pairs No. of Markers Genetic Correlation (SE) P value
RA and CA 934,512 0.2327 (0.703) 0.7406
MSE and CA 1,024,525 −0.0238 (0.1599) 0.8815
RA and MSE 1,056,658 0.7732 (0.6504) 0.2345
RA=refractive astigmatism, CA=corneal astigmatism, MSE=mean spherical equivalent. P values refer to likelihood of non-zero correla-
tion between traits.
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astigmatism and spherical equivalent refractive error (Table 3 
and Table 4). The SNP heritability (h2) estimates for corneal 
and refractive astigmatism (~5% and ~1%, respectively) 
were lower than for the spherical equivalent (~23%); indeed, 
the SNP heritability estimates for corneal and refractive 
astigmatism were not significantly different from zero. The 
genetic correlation estimates also had high standard errors 
and therefore yielded very imprecise estimates (Table 4). 
These hinted at a high genetic correlation between corneal 
astigmatism and the spherical equivalent; however, in view of 
the low SNP heritability estimate for the astigmatism traits, 
these findings imply that much larger sample sizes and/or a 
more homogeneous population sample is needed to obtain 
robust findings.
DISCUSSION
This GWAS for corneal astigmatism in a combined sample 
of Europeans and Asians identified a single genome-wide 
significant locus in the promoter region of the PDGFRA gene, 
replicating the previous discovery of this corneal astigmatism 
locus by Fan et al. [16] in a predominantly Asian sample. 
Therefore, despite a fourfold increase in sample size (n=31,370 
versus n=7,719) compared to the only previous GWAS meta-
analysis for corneal astigmatism [16], the standard, single-
marker GWAS analysis performed here did not identify any 
new loci. GWAS analyses for spherical equivalent and other 
morphological traits in equivalently sized samples have iden-
tified dozens of independent risk loci [18,19]. This paucity of 
GWAS loci for corneal astigmatism mirrors that observed in 
a previous large-scale GWAS for refractive astigmatism [17]. 
Our LD score regression-based SNP heritability estimates 
for corneal astigmatism (h2 ~5%) and refractive astigmatism 
(h2 ~1%)—the first ever estimates for these traits—were also 
much lower than those for the spherical equivalent (h2 ~23%), 
suggesting that common, additively acting SNPs make a 
relatively minor contribution to the development of astigma-
tism. In the study by Fan et al. [16] that originally identified 
the association between SNPs close to the PDGFRA gene 
and corneal astigmatism, the authors speculated that the 
underlying causal mechanism was common to populations 
of diverse ancestry and not specifically to those of Asian 
origin. This was based on the knowledge that their GWAS 
included individuals of Indian ancestry, who are more closely 
genetically related to Europeans than East Asians [16]. Our 
findings support this theory.
The association between PDGFRA SNPs and corneal 
astigmatism has been replicated in a previous study of Euro-
peans (n=1968) but not in another smaller study (n=1013) 
[41,43]. Variants at this locus were not associated with 
refractive astigmatism in GWAS meta-analyses of n=45,287 
participants [17] yet were associated with corneal curvature 
in an Asian sample [15] and with both corneal curvature and 
axial length (but not refractive error) in a European sample 
[41]. This complex series of findings suggests a role for 
PDGRFA in the regulation of eye size and corneal astigma-
tism; however, the underlying mechanism of action remains 
uncertain.
In contrast to the single-marker analyses, gene-based 
analysis did provide new insight into the genetic basis of 
corneal astigmatism, implicating the genes ACP2, CLDN7, 
CTDNEP1, ELP5, and TNFAIP8L3. Three of these five 
genes—CLDN7, CTDNEP1, and ELP5—are tightly clustered 
on chromosome 11, with their respective (gene-based) asso-
ciation signals sharing many variants in common. Therefore, 
a parsimonious interpretation is that only one of the genes 
has a causal association with astigmatism and that the other 
two genes are false-positive associations detected due to the 
signal from the causal gene. Of the three genes, CLDN7, 
which encodes the claudin-7 membrane protein [44], appears 
to be the most biologically plausible candidate. Claudins are 
responsible for tight junction formation and function [45], 
with claudin-7 being the subtype present in human corneal 
epithelium and endothelium [46]. Currently, how claudin-7 
may contribute to the development of corneal astigmatism 
is unclear. The acid phosphatase 2, lysosomal gene (ACP2) 
is located on chromosome 17 and codes for the beta subunit 
of the degradative enzyme, lysosomal acid phosphatase 
(LAP). Interestingly, LAP activity is enhanced in keratoconic 
corneas [47,48]. The TNFAIP8L3 gene located on chromo-
some 15 codes for TNF alpha-induced protein 8 like 3, which 
is preferentially expressed in secretory epithelial cells [49]. 
TNFAIP8L3 is implicated as a negative regulator of inflam-
mation (and carcinogenesis) through its role in TNFα and 
phospholipid signaling. Based on this evidence, the CLDN7, 
ACP2, and TNFAIP8L3 genes are promising susceptibility 
genes for corneal astigmatism. It is important to note that 
while the statistical support for the above three genes was 
much stronger in the MAGMA analysis than in the VEGAS2 
analysis, the two software programs similarly ranked the 
most strongly associated genes. This commonality between 
the MAGMA and VEGAS2 results provides greater confi-
dence that the findings are robust than would be the case for 
findings identified using either software program alone, as 
the statistical models and hypothesis tests used by the two 
programs differ, especially regarding the adjustment for vari-
ants in LD.
The strengths of this investigation are that data 
from multiple population samples were combined and 
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meta-analyzed and that gene-based and pathway-based 
follow-up analyses were undertaken to leverage new biologic 
insights into the genetics of astigmatism. The weaknesses 
were that although the samples included both European 
and Asian ancestry individuals, trans-ethnic meta-analysis 
[50] was not performed due to the small size of the Asian 
sample compared to the European sample and that the age 
spectrum of the participants was very broad. The latter point 
is an important consideration because astigmatism does not 
remain constant during life, with changes in both magnitude 
and orientation occurring with age [1]. For example, in child-
hood, astigmatism tends to be WTR, whereas in older adults 
this orientation typically changes to ATR. Our study design 
sought to overcome some of this variation by considering only 
the magnitude of corneal astigmatism (i.e., no consideration 
of astigmatism axis) and by using a case-control classification 
scheme, with the aim of reducing the impact of the subtle 
changes in astigmatism that commonly occur with age.
In conclusion, this GWAS meta-analysis for corneal 
astigmatism replicated the discovery of a genome-wide 
significant locus near the PDGFRA gene [16] and provided 
strong evidence that this locus is important in both Asians and 
Europeans (Figure 4). Three novel candidate genes, CLDN7, 
ACP2, and TNFAIP8L3, were identified using gene-based 
analyses that leveraged data from across genomic regions 
rather than from examining one genetic marker at a time. 
These novel genes warrant further investigation to understand 
their role in the pathogenesis of corneal astigmatism. Finally, 
exploiting the recently introduced LD score regression tech-
nique, we estimated the SNP heritability of corneal astigma-
tism (and refractive astigmatism) to be much lower than that 
for spherical equivalent refractive error (Table 3) [51]. This 
implies that astigmatism must be under greater influence 
of rare genetic variants or environmental risk factors than 
spherical equivalent or that the common genetic variants that 
contribute to astigmatism have non-additive effects.
APPENDIX 1. INSTRUMENT FOR MEASURING 
CORNEAL CURVATURE.
To access the data, click or select the words “Appendix 1”
APPENDIX 2. MANHATTAN PLOTS FOR THE 
SEPARATE ANCESTRY/AGE STRATA FIXED 
EFFECTS META-ANALYSES.
Manhattan plots for the separate ancestry/age strata fixed 
effects meta-analyses. Y-axes show negative log10 p-values 
and X-axes show genomic position. Red line corresponds to 
P = 5 x 10-8, blue line corresponds to P = 1 x 10-5. Panel A, 
European ancestry, aged >25 years; B, European ancestry, 
aged <25 years; C, Asian ancestry, aged >25 years; D, Asian 
ancestry, aged <25 years. To access the data, click or select 
the words “Appendix 2”
APPENDIX 3. QUANTILE-QUANTILE PLOTS FOR 
THE SEPARATE ANCESTRY/AGE STRATA FIXED 
EFFECTS META-ANALYSES.
Y-axes show observed negative log10 p-values and X-axes 
show expected negative log10 p-values according to the null 
hypothesis of no genetic association. Red line is the line of 
unity (y = x). Panel A, European ancestry, aged >25 years; B, 
European ancestry, aged <25 years; C, Asian ancestry, aged 
>25 years; D, Asian ancestry, aged <25 years. To access the 
data, click or select the words “Appendix 3”
APPENDIX 4. MOST STRONGLY ASSOCIATED 
MARKER IN EACH REGION IN THE GWAS META-
ANALYSIS OF ALL EUROPEANS AGED >25 YEARS.
To access the data, click or select the words “Appendix 4”
APPENDIX 5. MOST STRONGLY ASSOCIATED 
MARKER IN EACH REGION IN THE GWAS META-
ANALYSIS OF ALL EUROPEANS AGED <25 YEARS.
To access the data, click or select the words “Appendix 5”
APPENDIX 6. MOST STRONGLY ASSOCIATED 
MARKER IN EACH REGION IN THE GWAS META-
ANALYSIS OF ALL ASIANS AGED >25 YEARS.
To access the data, click or select the words “Appendix 6”
APPENDIX 7. MOST STRONGLY ASSOCIATED 
MARKER IN EACH REGION IN THE GWAS META-
ANALYSIS OF ALL ASIANS AGED <25 YEARS.
To access the data, click or select the words “Appendix 7”
APPENDIX 8. TOP 10 GENES FROM VEGAS2 GENE-
BASED ASSOCIATION TEST WITH ±50KB BUFFERS 
FOR ALL EUROPEANS.
Start and stop positions listed include ±50kb buffers. nSNPs: 
number of variants included in gene region. Test Statistic: 
gene-based χ2 test statistic to nSNPs degrees of freedom. 
P-value: obtained from Test Statistic and adjusting for LD 
between variants. FDR: false discovery rate (likelihood of 
gene association being a false positive result). Top SNP: 
variant within gene locus with strongest association signal 
from previous SNP-based association test. Genes shown in 
bold were also identified with MAGMA (Appendix 9). To 
access the data, click or select the words “Appendix 8”
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APPENDIX 9. TOP 10 GENES FROM MAGMA GENE-
BASED ASSOCIATION TEST WITH ±50KB BUFFERS 
FOR ALL EUROPEANS.
Start and stop positions listed include ±50kb buffers. nSNPs: 
number of variants included in gene region. Z Statistic: gene-
based test statistic. P-value: obtained from Z Statistic under 
the assumption of a normally distributed model. FDR: false 
discovery rate (likelihood of gene association being a false 
positive result). Genes shown in bold were also identified 
with VEGAS2 (Appendix 8). To access the data, click or 
select the words “Appendix 9”
ACKNOWLEDGMENTS AND STUDY 
INFORMATION
ALSPAC. The Avon Longitudinal Study of Parents and Chil-
dren (ALSPAC) team and authors are extremely grateful to 
all the families who took part in this study, the midwives for 
their help in recruiting them, and the whole ALSPAC team, 
which includes interviewers, computer and laboratory techni-
cians, clerical workers, research scientists, volunteers, 
managers, receptionists and nurses. The UK Medical 
Research Council and Wellcome Trust (Grant ref: 
102215/2/13/2) and the University of Bristol provide core 
support for ALSPAC. GWAS data was generated by Sample 
Logistics and Genotyping Facilities at Wellcome Sanger 
Institute and LabCorp (Laboratory Corportation of America) 
using support from 23andMe. This publication is the work of 
the authors and JAG and CW will serve as guarantors for the 
contents of this paper. This research was specifically funded 
by NIHR Senior Research Fellowship SRF-2015–08–005 
(CW) and a Wellcome Trust ISSF Populations Pilot Award 
(grant 508353/509506). Ethical approval for the ALSPAC 
study was obtained from the ALSPAC Ethics and Law 
Committee and the Local Research Ethics Committees. 
Please note that the ALSPAC study website contains details 
of all the data that is available through a fully searchable data 
dictionary: http://www.bris.ac.uk/alspac/researchers/data-
access/data-dictionary/. ALSPAC children with available 
genotype data and corneal curvature phenotype information 
formed the GWAS sample (Table 1). A description of the 
ALSPAC study cohort is available [52]. BES. The Beijing Eye 
Study (BES) was supported by National Natural Science 
Foundation of China (grant # 81770890). This publication is 
the work of the authors and YXW and JBJ will serve as guar-
antors for the contents of this paper. The study was approved 
by the Medical Ethics Committee of the Beijing Tongren 
Hospital. A description of the BES study cohort is available 
[53]. BMES. The Blue Mountains Eye Study (BMES) 
acknowledge funding from the National Health and Medical 
Research Council of Australia (NHMRC) Senior Research 
Fellowship 1138585 (PNB). The Centre for Eye Research 
Australia (CERA) receives Operational Infrastructure 
Support from the Victorian Government. Details of the 
BMES cohort have been published previously [54]. EPIC. 
The European Prospective Investigation of Cancer (EPIC)-
Norfolk infrastructure and core functions are supported by 
grants from the Medical Research Council (G1000143) and 
Cancer Research UK (C864/A14136). The clinic for the third 
health examination was funded by Research into Aging (262). 
Mr Khawaja was a Wellcome Trust Clinical Research Fellow 
at the time of analysis. The EPIC-Norfolk Eye Study was 
performed following the principles of the Declaration of 
Helsinki and the Research Governance Framework for Health 
and Social Care. The study was approved by the Norfolk 
Local Research Ethics Committee (05/Q0101/191) and East 
Norfolk & Waveney NHS Research Governance Committee 
(2005EC07L). All participants gave written, informed 
consent. A description of the EPIC study cohort is available 
[55]. FITSA. Finnish Twin Study on Aging (FITSA) is a 
study of genetic and environmental effects on the disablement 
process in older female twins. The study cohort of 13,888 
adult twin pairs started in 1975. Altogether 103 MZ and 114 
DZ twin pairs (424 individuals, all women of European 
ancestry) aged 63–76 years living in Finland took part in 
multiple laboratory examinations in 2000 and 2003, and 
responded in questionnaires in 2011. Before the examinations, 
the subjects provided a written informed consent according 
to the Declaration of Helsinki. The study protocol was 
approved by the ethics committee of the Central Hospital 
District of Central Finland. FITSA was supported by 
ENGAGE (FP7-HEALTH-F4–2007, 201,413); European 
Union through the GENOMEUTWIN project (QLG2-CT-
2002–01254); the Academy of Finland Center of Excellence 
in Complex Disease Genetics (213506, 129680); the Academy 
of Finland Aging Programme; and the Finnish Ministry of 
Culture and Education and University of Jyväskylä, 
Silmäsäätiö Foundation and Evald & Hilda Nissi Foundation. 
For FITSA the contributions of Emmi Tikkanen, Samuli 
Ripatti, Markku Kauppinen, Taina Rantanen and Jaakko 
Kaprio are acknowledged. A description of the FITSA cohort 
has been published [56]. Generation R. The Generation R 
study is conducted by the Erasmus Medical Centre in close 
collaboration with the School of Law and Faculty of Social 
Sciences of the Erasmus University Rotterdam, the Municipal 
Health Service Rotterdam, the Rotterdam Homecare Founda-
tion, and the Stichting Trombosedienst & Artsenlaboratorium 
Rijnmond (Star-MDC), Rotterdam. We gratefully acknowl-
edge the contribution of the children and parents, as well as 
the participating general practitioners, hospitals, midwives, 
Molecular Vision 2018; 24:127-142 <http://www.molvis.org/molvis/v24/127> © 2018 Molecular Vision 
138
and pharmacies in Rotterdam. The Generation R study is 
made possible by financial support from the Erasmus Medical 
Centre, Rotterdam; the Netherlands Organisation for Scien-
tific Research (NWO); the Netherlands Organisation for 
Health Research and Development (ZonMw); the Dutch 
Ministry of Education, Culture and Science; the Dutch 
Ministry of Health, Welfare, and Sports; the European 
Commission (DG XII); and UitZicht (Grant 2013–24). The 
study protocol was approved by the Medical Ethical 
Committee of the Erasmus Medical Centre, Rotterdam (MEC 
217.595/2002/20), and written informed consent was obtained 
from all participants. Research was conducted according to 
the declaration of Helsinki. A description of the Generation 
R study has been published [57]. Gutenberg Health Study 
(GHS 1 and GHS 2). The Gutenberg Health Study is a 
population-based, prospective, observational cohort study in 
mid-western Germany that includes consecutive follow-ups 
every five years. The primary study aim is to evaluate and 
improve cardiovascular risk stratification and the general 
health status of the population. The baseline examination 
included a total of 15,010 participants aged 35 to 74 years and 
took place from 2007 to 2012. The participants were randomly 
drawn and equally stratified for sex, residence (urban or 
rural) and for each decade of age. Exclusion criteria were the 
following: insufficient knowledge of German and physical or 
mental inability to participate in the examinations in the 
study center. The study protocol and study documents were 
approved by the local ethics committee of the Medical 
Chamber of Rhineland-Palatinate, Germany (reference no. 
837.020.07; original vote: 22.3.2007, latest update: 
20.10.2015). According to the tenets of the Declaration of 
Helsinki, written informed consent was obtained from all 
participants before their entry into the study. The Gutenberg 
Health Study is funded through the government of Rhineland-
Palatinate (“Stiftung Rheinland-Pfalz für Innovation,” 
contract AZ 961–386261/733), the research programs “Wissen 
schafft Zukunft” and “Center for Translational Vascular 
Biology (CTVB)” of the Johannes Gutenberg-University of 
Mainz, the National Genome Network “NGFNplus” by the 
Federal Ministry of Education and Research, Germany 
(A301GS0833) and its contracts with Boehringer Ingelheim 
and PHILIPS Medical Systems. We thank all study partici-
pants for their willingness to provide data for this research 
project and we are indebted to all coworkers for their enthu-
siastic commitment. A description of the ophthalmic arm of 
the GHS has been published [58]. OGP. The Ogliastra Genetic 
Park (OGP) study authors would like to express their grati-
tude to all the study participants for their contributions, to the 
municipal administrations for their economic and logistic 
support and, to the whole OGP team, which includes 
interviewers, computer and laboratory technicians, research 
scientists, physicians and nurses. This research was supported 
by grant from the Italian Ministry of Education, University 
and Research (MIUR) no: 5571/DSPAR/2002. The research 
protocol of the study was approved by the institutional review 
board of the Italian Ministry of Education, University and 
Research. It adheres to the tenets of the declaration of 
Helsinki, furthermore written informed consent was obtained 
from all participants. A description of the OGP study cohort 
has been published [59]. RAINE (Western Australian Preg-
nancy Cohort). We are grateful to all the study participants. 
We also thank the Raine Study and Lions Eye Institute (LEI) 
research staff for cohort coordination and data collection. The 
core management of the Raine Study is funded by The 
University of Western Australia (UWA), The Telethon Insti-
tute for Child Health Research, Raine Medical Research 
Foundation, UWA Faculty of Medicine, Dentistry and Health 
Sciences, Women’s and Infant’s Research Foundation and 
Curtin University. Genotyping was funded by Australian 
National Health and Medical Research Council (NHMRC) 
project grant 1021105. Support for the REHS was provided by 
LEI, the Australian Foundation for the Prevention of Blind-
ness and ORIA. SY is supported by NHMRC CJ Martin Early 
Career Fellowship (#1111437). A description of the RAINE 
Eye Health Study study cohort is available [60]. Rotterdam 
Study (RS1, RS2, RS3). The Rotterdam Study is a prospec-
tive population-based cohort study in the elderly living in 
Ommoord, a suburb of Rotterdam, the Netherlands. In brief, 
the Rotterdam Study consists of 3 independent cohorts: RS1, 
RS2, and RS3. For the current analysis, 5,328 residents aged 
55 years and older were included from RS1, 2,009 partici-
pants aged 55 and older from RS2, and 1,970 aged 45 and 
older from RS 3. 99% of subjects were of European ancestry. 
Participants underwent multiple physical examinations with 
regular intervals from 1991 to present, including a non-dilated 
automated measurement of refractive error using a Topcon 
RM-A2000 autorefractor. All measurements in RS-1–3 were 
conducted after the Medical Ethics Committee of the Erasmus 
University had approved the study protocols and all partici-
pants had given a written informed consent in accordance 
with the Declaration of Helsinki. The Rotterdam Study was 
supported by the Dutch governmental Innovational Research 
Incentives Scheme Grant (VICI 91815655); Horizon2020 
ERC Consolidator Grant (648268); Erasmus Medical Center 
and Erasmus University, Rotterdam, The Netherlands; Neth-
erlands Organization for Health Research and Development 
(ZonMw); UitZicht; the Research Institute for Diseases in the 
Elderly; the Ministry of Education, Culture and Science; the 
Ministry for Health, Welfare and Sports; the European 
Commission (DG XII); the Municipality of Rotterdam; the 
Molecular Vision 2018; 24:127-142 <http://www.molvis.org/molvis/v24/127> © 2018 Molecular Vision 
139
Netherlands Genomics Initiative/NWO; Center for Medical 
Systems Biology of NGI; Lijf en Leven; Henkes Stichting; 
Landelijke Stichting voor Blinden en Slechtzienden; 
Oogfonds; MaculaFonds. We acknowledge Ada Hooghart, 
Corina Brussee, Riet Bernaerts-Biskop, Patricia van Hilten, 
Pascal Arp, Jeanette Vergeer, Marijn Verkerk; Sander 
Bervoets for their valuable contributions. A description of the 
Rotterdam study has been published [61]. SCES, SIMES and 
SINDI. The Singapore Chinese Eye Study (SCES), Singapore 
Malay Eye Study (SiMES) and Singapore Indian Eye Study 
(SINDI) were supported by the National Medical Research 
Council (NMRC), Singapore (grants 0796/2003, 1176/2008, 
1149/2008, STaR/0003/2008, 1249/2010, CG/SERI/2010, 
CIRG/1371/2013, and CIRG/1417/2015), and Biomedical 
Research Council, Singapore (08/1/35/19/550 and 
09/1/35/19/616). Ching-Yu Cheng is supported by an award 
from NMRC (CSA/033/2012). Descriptions of the SCES, 
SIMES and SINDI cohorts have been published [62-64]. 
SCORM. The Singapore Cohort Study of the Risk Factors 
for Myopia (SCORM) was supported by the Biomedical 
Research Council (BMRC) 06/1/21/19/466. A description of 
the SCORM cohort has been published [65]. STARS. The 
Singaporean Chinese in the Strabismus, Amblyopia, and 
Refractive Error Study (STARS) was supported by National 
Medical Research Council (NMRC), Singapore (grants 
1176/2008). A description of the STARS cohort has been 
published [66]. TwinsUK. The TwinsUK adult twin registry 
based at St. Thomas’ Hospital in London is a volunteer cohort 
of over 10,000 twins from the general population. Twins 
largely volunteered unaware of the eye studies, gave fully 
informed consent under a protocol reviewed by the St. 
Thomas’ Hospital Local Research Ethics Committee. 
TwinsUK is funded by the Wellcome Trust and the European 
Community's Seventh Framework Programme (FP7/2007–
2013). The study also receives support from the National 
Institute for Health Research Clinical Research Facility at 
Guy's and St. Thomas' National Health Service Foundation 
Trust and National Institute for Health Research Biomedical 
Research Centre at Guy's and St. Thomas' National Health 
Service Foundation Trust and King's College London. Kera-
tometry was obtained using the VX-120 ocular diagnostic 
device (Visionix®, Luneau Technology Group). A description 
of the TwinsUK study cohort is available [67]. CREAM 
Meta-analyses. This work was supported in part by the Intra-
mural Research Program of the National Human Genome 
Research Institute, National Institutes of Health.
REFERENCES
1. Read SA, Collins MJ, Carney LG. A review of astigmatism 
and its possible genesis.  Clin Exp Optom  2007; 90:5-19. .
2. Kee CS. Astigmatism and its role in emmetropization.  Exp 
Eye Res  2013; 114:89-95. .
3. Mozayan E, Lee JK. Update on astigmatism management. 
Curr Opin Ophthalmol  2014; 25:286-90. .
4. Somer D, Budak K, Demirci S, Duman S. Against-the-rule 
(ATR) astigmatism as a predicting factor for the outcome of 
amblyopia treatment.  Am J Ophthalmol  2002; 133:741-5. .
5. Dunne MC, Elawad ME, Barnes DA. A study of the axis 
of orientation of residual astigmatism.  Acta Ophthalmol 
(Copenh)  1994; 72:483-9. .
6. Keller PR, Collins MJ, Carney LG, Davis BA, vanSaarloos PP. 
The relation between corneal and total astigmatism.  Optom 
Vis Sci  1996; 73:86-91. .
7. Chu CH, Kee CS. Effects of optically imposed astigmatism on 
early eye growth in chicks.  PLoS One  2015; 10:e0117729-.
8. Gwiazda J, Scheiman M, Mohindra I, Held R. Astigmatism in 
children: changes in axis and amount from birth to six years. 
Invest Ophthalmol Vis Sci  1984; 25:88-92. .
9. Harvey EM, Dobson V, Miller JM, Schwiegerling J, Clifford-
Donaldson CE, Green TK, Messer DH. Prevalence of corneal 
astigmatism in Tohono O’odham Native American children 
6 months to 8 years of age.  Invest Ophthalmol Vis Sci  2011; 
52:4350-5. .
10. Huynh SC, Kifley A, Rose KA, Morgan IG, Mitchell P. Astig-
matism in 12-year-old Australian children: comparisons with 
a 6-year-old population.  Invest Ophthalmol Vis Sci  2007; 
48:73-82. .
11. Sanfilippo PG, Hewitt AW, Hammond CJ, Mackey DA. The 
heritability of ocular traits.  Surv Ophthalmol  2010; 55:561-
83. .
12. Parssinen O, Kauppinen M, Kaprio J, Koskenvuo M, Rantanen 
T. Heritability of refractive astigmatism: a population-based 
twin study among 63- to 75-year-old female twins.  Invest 
Ophthalmol Vis Sci  2013; 54:6063-7. .
13. Clementi M, Angi M, Forabosco P, Di Gianantonio E, Tenconi 
R. Inheritance of astigmatism: evidence for a major auto-
somal dominant locus.  Am J Hum Genet  1998; 63:825-30. .
14. Lopes MC, Hysi PG, Verhoeven VJ, Macgregor S, Hewitt AW, 
Montgomery GW, Cumberland P, Vingerling JR, Young TL, 
van Duijn CM, Oostra B, Uitterlinden AG, Rahi JS, Mackey 
DA, Klaver CC, Andrew T, Hammond CJ. Identification of a 
candidate gene for astigmatism.  Invest Ophthalmol Vis Sci 
2013; 54:1260-7. .
15. Han S, Chen P, Fan Q, Khor CC, Sim X, Tay WT, Ong RT, 
Suo C, Goh LK, Lavanya R, Zheng Y, Wu R, Seielstad M, 
Vithana E, Liu J, Chia KS, Lee JJ, Tai ES, Wong TY, Aung 
T, Teo YY, Saw SM. Association of variants in FRAP1 and 
PDGFRA with corneal curvature in Asian populations from 
Singapore.  Hum Mol Genet  2011; 20:3693-8. .
Molecular Vision 2018; 24:127-142 <http://www.molvis.org/molvis/v24/127> © 2018 Molecular Vision 
140
16. Fan Q, Zhou X, Khor CC, Cheng CY, Goh LK, Sim X, Tay WT, 
Li YJ, Ong RT, Suo C, Cornes B, Ikram MK, Chia KS, Seiel-
stad M, Liu J, Vithana E, Young TL, Tai ES, Wong TY, Aung 
T, Teo YY, Saw SM. Genome-wide meta-analysis of five 
Asian cohorts identifies PDGFRA as a susceptibility locus 
for corneal astigmatism.  PLoS Genet  2011; 7:e1002402-.
17. Li Q, Wojciechowski R, Simpson CL, Hysi PG, Verhoeven 
VJ, Ikram MK, Hohn R, Vitart V, Hewitt AW, Oexle K, 
Makela KM, MacGregor S, Pirastu M, Fan Q, Cheng CY, St 
Pourcain B, McMahon G, Kemp JP, Northstone K, Rahi JS, 
Cumberland PM, Martin NG, Sanfilippo PG, Lu Y, Wang 
YX, Hayward C, Polasek O, Campbell H, Bencic G, Wright 
AF, Wedenoja J, Zeller T, Schillert A, Mirshahi A, Lackner 
K, Yip SP, Yap MK, Ried JS, Gieger C, Murgia F, Wilson JF, 
Fleck B, Yazar S, Vingerling JR, Hofman A, Uitterlinden 
A, Rivadeneira F, Amin N, Karssen L, Oostra BA, Zhou X, 
Teo YY, Tai ES, Vithana E, Barathi V, Zheng Y, Siantar RG, 
Neelam K, Shin Y, Lam J, Yonova-Doing E, Venturini C, 
Hosseini SM, Wong HS, Lehtimaki T, Kahonen M, Raita-
kari O, Timpson NJ, Evans DM, Khor CC, Aung T, Young 
TL, Mitchell P, Klein B, van Duijn CM, Meitinger T, Jonas 
JB, Baird PN, Mackey DA, Wong TY, Saw SM, Parssinen 
O, Stambolian D, Hammond CJ, Klaver CC, Williams C, 
Paterson AD, Bailey-Wilson JE, Guggenheim JA. Cream 
Consortium. Genome-wide association study for refractive 
astigmatism reveals genetic co-determination with spherical 
equivalent refractive error: the CREAM consortium.  Hum 
Genet  2015; 134:131-46. .
18. Verhoeven VJ, Hysi PG, Wojciechowski R, Fan Q, Guggen-
heim JA, Hohn R, MacGregor S, Hewitt AW, Nag A, Cheng 
CY, Yonova-Doing E, Zhou X, Ikram MK, Buitendijk GH, 
McMahon G, Kemp JP, Pourcain BS, Simpson CL, Makela 
KM, Lehtimaki T, Kahonen M, Paterson AD, Hosseini SM, 
Wong HS, Xu L, Jonas JB, Parssinen O, Wedenoja J, Yip SP, 
Ho DW, Pang CP, Chen LJ, Burdon KP, Craig JE, Klein BE, 
Klein R, Haller T, Metspalu A, Khor CC, Tai ES, Aung T, 
Vithana E, Tay WT, Barathi VA. Consortium for Refractive 
Error and Myopia, Chen P, Li R, Liao J, Zheng Y, Ong RT, 
Doring A, Diabetes Control Complications Trial/Epidemi-
ology of Diabetes Interventions Complications Research 
Group, Evans DM, Timpson NJ, Verkerk AJ, Meitinger T, 
Raitakari O, Hawthorne F, Spector TD, Karssen LC, Pirastu 
M, Murgia F, Ang W, Wellcome Trust Case Control Consor-
tium, Mishra A, Montgomery GW, Pennell CE, Cumberland 
PM, Cotlarciuc I, Mitchell P, Wang JJ, Schache M, Janma-
hasatian S, Igo RP, Jr., Lass JH, Chew E, Iyengar SK, Fuchs’ 
Genetics Multi-Center Study Group, Gorgels TG, Rudan I, 
Hayward C, Wright AF, Polasek O, Vatavuk Z, Wilson JF, 
Fleck B, Zeller T, Mirshahi A, Muller C, Uitterlinden AG, 
Rivadeneira F, Vingerling JR, Hofman A, Oostra BA, Amin 
N, Bergen AA, Teo YY, Rahi JS, Vitart V, Williams C, Baird 
PN, Wong TY, Oexle K, Pfeiffer N, Mackey DA, Young TL, 
van Duijn CM, Saw SM, Bailey-Wilson JE, Stambolian D, 
Klaver CC, Hammond CJ. Genome-wide meta-analyses of 
multiancestry cohorts identify multiple new susceptibility 
loci for refractive error and myopia.  Nat Genet  2013; 
45:314-8. .
19. Kiefer AK, Tung JY, Do CB, Hinds DA, Mountain JL, 
Francke U, Eriksson N. Genome-wide analysis points to 
roles for extracellular matrix remodeling, the visual cycle, 
and neuronal development in myopia.  PLoS Genet  2013; 
9:e1003299-.
20. Tkatchenko AV, Tkatchenko TV, Guggenheim JA, Verho-
even VJ, Hysi PG, Wojciechowski R, Singh PK, Kumar A, 
Thinakaran G. Consortium for Refractive Error and Myopia, 
Williams C. APLP2 Regulates Refractive Error and Myopia 
Development in Mice and Humans.  PLoS Genet  2015; 
11:e1005432-.
21. Pickrell JK, Berisa T, Liu JZ, Segurel L, Tung JY, Hinds DA. 
Detection and interpretation of shared genetic influences on 
42 human traits.  Nat Genet  2016; 48:709-17. .
22. Bennett AG, Rabbetts RB. Clinical Visual Optics. Second 
Edition ed. London: Butterworths; 1989.
23. Howie BN, Donnelly P, Marchini J. A flexible and accurate 
genotype imputation method for the next generation of 
genome-wide association studies.  PLoS Genet  2009; 
5:e1000529-.
24. Li Y, Willer CJ, Ding J, Scheet P, Abecasis GR. MaCH: using 
sequence and genotype data to estimate haplotypes and 
unobserved genotypes.  Genet Epidemiol  2010; 34:816-34. .
25. Fan Q, Verhoeven VJM, Wojciechowski R, Barathi VA, 
Hysi PG, Guggenheim JA, Hohn R, Vitart V, Khawaja AP, 
Yamashiro K, Hosseini SM, Lehtimaki T, Lu Y, Haller T, 
Xie J, Delcourt C, Pirastu M, Wedenoja J, Gharahkhani 
P, Venturini C, Miyake M, Hewitt AW, Guo X, Mazur J, 
Huffman JE, Williams KM, Polasek O, Campbell H, Rudan 
I, Vatavuk Z, Wilson JF, Joshi PK, McMahon G, St Pourcain 
B, Evans DM, Simpson CL, Schwantes-An T-H, Igo RP, 
Mirshahi A, Cougnard-Gregoire A, Bellenguez C, Blettner 
M, Raitakari O, Kahonen M, Seppala I, Zeller T, Meitinger 
T. Consortium for Refractive E, Myopia, Ried JS, Gieger 
C, Portas L, van Leeuwen EM, Amin N, Uitterlinden AG, 
Rivadeneira F, Hofman A, Vingerling JR, Wang YX, Wang 
X, Tai-Hui Boh E, Ikram MK, Sabanayagam C, Gupta P, 
Tan V, Zhou L, Ho CEH, Lim We, Beuerman RW, Siantar 
R, Tai ES, Vithana E, Mihailov E, Khor C–C, Hayward 
C, Luben RN, Foster PJ, Klein BEK, Klein R, Wong H-S, 
Mitchell P, Metspalu A, Aung T, Young TL, He M, Parssinen 
O, van Duijn CM, Jin Wang J, Williams C, Jonas JB, Teo 
Y-Y, Mackey DA, Oexle K, Yoshimura N, Paterson AD, 
Pfeiffer N, Wong T-Y, Baird PN, Stambolian D, Wilson JEB, 
Cheng C-Y, Hammond CJ, Klaver CCW, Saw S-M, Rahi JS, 
Korobelnik J-F, Kemp JP, Timpson NJ, Smith GD, Craig JE, 
Burdon KP, Fogarty RD, Iyengar SK, Chew E, Janmahasa-
tian S, Martin NG, MacGregor S, Xu L, Schache M, Nangia 
V, Panda-Jonas S, Wright AF, Fondran JR, Lass JH, Feng 
S, Zhao JH, Khaw K-T, Wareham NJ, Rantanen T, Kaprio 
J, Pang CP, Chen LJ, Tam PO, Jhanji V, Young AL, Doring 
A, Raffel LJ, Cotch M-F, Li X, Yip SP, Yap MKH, Biino G, 
Vaccargiu S, Fossarello M, Fleck B, Yazar S, Tideman JWL, 
Tedja M, Deangelis MM, Morrison M, Farrer L, Zhou X, 
Chen W, Mizuki N, Meguro A, Makela KM. Meta-analysis 
of gene-environment-wide association scans accounting for 
Molecular Vision 2018; 24:127-142 <http://www.molvis.org/molvis/v24/127> © 2018 Molecular Vision 
141
education level identifies additional loci for refractive error. 
Nat Commun  2016; 7:11008-.
26. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, 
Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, Sham 
PC. PLINK: a tool set for whole-genome association and 
population-based linkage analyses.  Am J Hum Genet  2007; 
81:559-75. .
27. Aulchenko YS, Struchalin MV, van Duijn CM. ProbABEL 
package for genome-wide association analysis of imputed 
data.  BMC Bioinformatics  2010; 11:134-.
28. Winkler TW, Day FR, Croteau-Chonka DC, Wood AR, Locke 
AE, Mägi R, Ferreira T, Fall T, Graff M, Justice AE. Luan 
Ja, Gustafsson S, Randall JC, Vedantam S, Workalemahu 
T, Kilpeläinen TO, Scherag A, Esko T, Kutalik Z, Heid IM, 
Loos RJF, The Genetic Investigation of Anthropometric 
Traits C. Quality control and conduct of genome-wide asso-
ciation meta-analyses.  Nat Protoc  2014; 9:1192-212. .
29. Willer CJ, Li Y, Abecasis GR. METAL: fast and efficient meta-
analysis of genomewide association scans.  Bioinformatics 
2010; 26:2190-1. .
30. Magi R, Morris AP. GWAMA: software for genome-wide 
association meta-analysis.  BMC Bioinformatics  2010; 
11:288-.
31. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring 
inconsistency in meta-analyses.  BMJ  2003; 327:557-60. .
32. Sham PC, Purcell SM. Statistical power and significance 
testing in large-scale genetic studies.  Nat Rev Genet  2014; 
15:335-46. .
33. Pruim RJ, Welch RP, Sanna S, Teslovich TM, Chines PS, 
Gliedt TP, Boehnke M, Abecasis GR, Willer CJ. LocusZoom: 
regional visualization of genome-wide association scan 
results.  Bioinformatics  2010; 26:2336-7. .
34. Yang J, Ferreira T, Morris AP, Medland SE, Madden PAF, 
Heath AC, Martin NG, Montgomery GW, Weedon MN, Loos 
RJ, Frayling TM, McCarthy MI, Hirschhorn JN, Goddard 
ME, Visscher PM, Genetic Invest AT. Meta-A DIGR. Condi-
tional and joint multiple-SNP analysis of GWAS summary 
statistics identifies additional variants influencing complex 
traits.  Nat Genet  2012; 44:369-U170. .
35. Mishra A, Macgregor S. VEGAS2: Software for More Flexible 
Gene-Based Testing.  Twin Res Hum Genet  2015; 18:86-91. .
36. de Leeuw CA, Mooij JM, Heskes T, Posthuma D. MAGMA: 
generalized gene-set analysis of GWAS data.  PLOS Comput 
Biol  2015; 11:e1004219-.
37. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, 
Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub 
TR, Lander ES, Mesirov JP. Gene set enrichment analysis: 
a knowledge-based approach for interpreting genome-
wide expression profiles.  Proc Natl Acad Sci USA  2005; 
102:15545-50. .
38. Bulik-Sullivan BK, Loh P-R, Finucane HK, Ripke S, Yang J. 
Schizophrenia Working Group of the Psychiatric Genomics 
C, Patterson N, Daly MJ, Price AL, Neale BM. LD Score 
regression distinguishes confounding from polygenicity in 
genome-wide association studies.  Nat Genet  2015; 47:291-5. 
.
39. Bulik-Sullivan B, Finucane HK, Anttila V, Gusev A, Day 
FR, Loh P-R. ReproGen C, Psychiatric Genomics C, 
Genetic Consortium for Anorexia Nervosa of the Wellcome 
Trust Case Control C, Duncan L, Perry JRB, Patterson N, 
Robinson EB, Daly MJ, Price AL, Neale BM. An atlas of 
genetic correlations across human diseases and traits.  Nat 
Genet  2015; 47:1236-41. .
40. Mishra A, Yazar S, Hewitt AW, Mountain JA, Ang W, Pennell 
CE, Martin NG, Montgomery GW, Hammond CJ, Young TL, 
Macgregor S, Mackey DA. Genetic variants near PDGFRA 
are associated with corneal curvature in Australians.  Invest 
Ophthalmol Vis Sci  2012; 53:7131-6. .
41. Guggenheim JA, McMahon G, Kemp JP, Akhtar S, St Pour-
cain B, Northstone K, Ring SM, Evans DM, Smith GD, 
Timpson NJ, Williams C. A genome-wide association study 
for corneal curvature identifies the platelet-derived growth 
factor receptor alpha gene as a quantitative trait locus for eye 
size in white Europeans.  Mol Vis  2013; 19:243-53. .
42. Brodie A, Azaria JR, Ofran Y. How far from the SNP may the 
causative genes be?  Nucleic Acids Res  2016; 44:6046-54. .
43. Yazar S, Mishra A, Ang W, Kearns LS, Mountain JA, Pennell 
C, Montgomery GW, Young TL, Hammond CJ, Macgregor S, 
Mackey DA, Hewitt AW. Interrogation of the platelet-derived 
growth factor receptor alpha locus and corneal astigmatism 
in Australians of Northern European ancestry: results of a 
genome-wide association study.  Mol Vis  2013; 19:1238-46. .
44. Hewitt KJ, Agarwal R, Morin PJ. The claudin gene family: 
expression in normal and neoplastic tissues.  BMC Cancer 
2006; 6:186-.
45. Tsukita S, Furuse M. Pores in the wall: claudins constitute 
tight junction strands containing aqueous pores.  J Cell Biol 
2000; 149:13-6. .
46. Inagaki E, Hatou S, Yoshida S, Miyashita H, Tsubota K, Shim-
mura S. Expression and distribution of claudin subtypes in 
human corneal endothelium.  Invest Ophthalmol Vis Sci 
2013; 54:7258-65. .
47. Sawaguchi S, Yue BY, Sugar J, Gilboy JE. Lysosomal enzyme 
abnormalities in keratoconus.  Arch Ophthalmol  1989; 
107:1507-10. .
48. Maruyama Y, Wang X, Li Y, Sugar J, Yue BY. Involvement 
of Sp1 elements in the promoter activity of genes affected in 
keratoconus.  Invest Ophthalmol Vis Sci  2001; 42:1980-5. .
49. Cui J, Hao C, Zhang W, Shao J, Zhang N, Zhang G, Liu S. 
Identical expression profiling of human and murine TIPE3 
protein reveals links to its functions.  J Histochem Cytochem 
2015; 63:206-16. .
50. Wang X, Chua HX, Chen P, Ong RT, Sim X, Zhang W, 
Takeuchi F, Liu X, Khor CC, Tay WT, Cheng CY, Suo C, Liu 
J, Aung T, Chia KS, Kooner JS, Chambers JC, Wong TY, Tai 
ES, Kato N, Teo YY. Comparing methods for performing 
trans-ethnic meta-analysis of genome-wide association 
studies.  Hum Mol Genet  2013; 22:2303-11. .
Molecular Vision 2018; 24:127-142 <http://www.molvis.org/molvis/v24/127> © 2018 Molecular Vision 
142
51. Guggenheim JA, St Pourcain B, McMahon G, Timpson NJ, 
Evans DM, Williams C. Assumption-free estimation of the 
genetic contribution to refractive error across childhood. 
Mol Vis  2015; 21:621-32. .
52. Boyd A, Golding J, Macleod J, Lawlor DA, Fraser A, 
Henderson J, Molloy L, Ness A, Ring S, Davey Smith G. 
Cohort Profile: the ‘children of the 90s’–the index offspring 
of the Avon Longitudinal Study of Parents and Children.  Int 
J Epidemiol  2013; 42:111-27. .
53. Wang YX, Zhang JS, You QS, Xu L, Jonas JB. Ocular diseases 
and 10-year mortality: the Beijing Eye Study 2001/2011.  Acta 
Ophthalmol  2014; 92:e424-8. .
54. Schache M, Richardson AJ, Mitchell P, Wang JJ, Rochtchina 
E, Viswanathan AC, Wong TY, Saw SM, Topouzis F, Xie J, 
Sim X, Holliday EG, Attia J, Scott RJ, Baird PN. Genetic 
association of refractive error and axial length with 15q14 but 
not 15q25 in the Blue Mountains Eye Study cohort.  Ophthal-
mology  2013; 120:292-7. .
55. Khawaja AP, Chan MP, Hayat S, Broadway DC, Luben R, 
Garway-Heath DF, Sherwin JC, Yip JL, Dalzell N, Wareham 
NJ, Khaw KT, Foster PJ. The EPIC-Norfolk Eye Study: 
rationale, methods and a cross-sectional analysis of visual 
impairment in a population-based cohort.  BMJ Open  2013; 
3:e002684-.
56. Kaprio J, Koskenvuo M. Genetic and Environmental Factors 
in Complex Diseases: The Older Finnish Twin Cohort.  Twin 
Res  2012; 5:358-65. .
57. Jaddoe VW, Mackenbach JP, Moll HA, Steegers EA, Tiemeier 
H, Verhulst FC, Witteman JC, Hofman A. The Generation 
R Study: Design and cohort profile.  Eur J Epidemiol  2006; 
21:475-84. .
58. Hohn R, Kottler U, Peto T, Blettner M, Munzel T, Blanken-
berg S, Lackner KJ, Beutel M, Wild PS, Pfeiffer N. The 
ophthalmic branch of the Gutenberg Health Study: study 
design, cohort profile and self-reported diseases.  PLoS One 
2015; 10:e0120476-.
59. Biino G, Balduini CL, Casula L, Cavallo P, Vaccargiu S, 
Parracciani D, Serra D, Portas L, Murgia F, Pirastu M. 
Analysis of 12,517 inhabitants of a Sardinian geographic 
isolate reveals that predispositions to thrombocytopenia and 
thrombocytosis are inherited traits.  Haematologica  2010; 
96:96-101. .
60. Yazar S, Forward H, McKnight CM, Tan A, Soloshenko A, 
Oates SK, Ang W, Sherwin JC, Wood D, Mountain JA, 
Pennell CE, Hewitt AW, Mackey DA. Raine eye health study: 
design, methodology and baseline prevalence of ophthalmic 
disease in a birth-cohort study of young adults.  Ophthalmic 
Genet  2013; 34:199-208. .
61. Hofman A, Brusselle GG, Darwish Murad S, van Duijn CM, 
Franco OH, Goedegebure A, Ikram MA, Klaver CC, Nijsten 
TE, Peeters RP, Stricker BH, Tiemeier HW, Uitterlinden AG, 
Vernooij MW. The Rotterdam Study: 2016 objectives and 
design update.  Eur J Epidemiol  2015; 30:661-708. .
62. Lavanya R, Jeganathan VS, Zheng Y, Raju P, Cheung N, Tai 
ES, Wang JJ, Lamoureux E, Mitchell P, Young TL, Cajucom-
Uy H, Foster PJ, Aung T, Saw SM, Wong TY. Methodology 
of the Singapore Indian Chinese Cohort (SICC) eye study: 
quantifying ethnic variations in the epidemiology of eye 
diseases in Asians.  Ophthalmic Epidemiol  2009; 16:325-36. .
63. Foong AW, Saw SM, Loo JL, Shen S, Loon SC, Rosman M, 
Aung T, Tan DT, Tai ES, Wong TY. Rationale and meth-
odology for a population-based study of eye diseases in 
Malay people: The Singapore Malay eye study (SiMES). 
Ophthalmic Epidemiol  2007; 14:25-35. .
64. Pan CW, Wong TY, Lavanya R, Wu RY, Zheng YF, Lin XY, 
Mitchell P, Aung T, Saw SM. Prevalence and risk factors for 
refractive errors in Indians: the Singapore Indian Eye Study 
(SINDI).  Invest Ophthalmol Vis Sci  2011; 52:3166-73. .
65. Saw SM, Shankar A, Tan SB, Taylor H, Tan DT, Stone RA, 
Wong TY. A cohort study of incident myopia in Singaporean 
children.  Invest Ophthalmol Vis Sci  2006; 47:1839-44. .
66. Dirani M, Chan YH, Gazzard G, Hornbeak DM, Leo SW, 
Selvaraj P, Zhou B, Young TL, Mitchell P, Varma R, Wong 
TY, Saw SM. Prevalence of refractive error in Singaporean 
Chinese children: the strabismus, amblyopia, and refractive 
error in young Singaporean Children (STARS) study.  Invest 
Ophthalmol Vis Sci  2010; 51:1348-55. .
67. Moayyeri A, Hammond CJ, Valdes AM, Spector TD. Cohort 
Profile: TwinsUK and healthy ageing twin study.  Int J Epide-
miol  2013; 42:76-85. .
Articles are provided courtesy of Emory University and the Zhongshan Ophthalmic Center, Sun Yat-sen University, P.R. China. 
The print version of this article was created on 5 February 2018. This reflects all typographical corrections and errata to the 
article through that date. Details of any changes may be found in the online version of the article.
